About Zephyrus Biosciences
Zephyrus Biosciences is a Healthcare company based in Berkeley (United States) founded in 2013, and was acquired by Bio-Techne in March 2016. Single-cell protein analysis tools are commercialized for research markets. Zephyrus Biosciences has raised $1.5 million across 2 funding rounds from investors including NIH, Bio-Techne and Life Science Angels. The company was acqui-hired. Zephyrus Biosciences offers products and services including Antibodies, ELISA Kits, Simple Plex Assays, and Simple Western Instruments. Its focus areas include Life Sciences, Life Sciences Platforms and Tools and Diversified. Its competitors include Bio Rad, Quanterix and Biocare Medical; 2 of its 3 listed competitors have raised funding.
Company details
Zephyrus Biosciences was founded in 2013 in Berkeley, United States, within the biotechnology sector. The scWestern System is being commercialized to enable single-cell protein analysis for stem cell and cancer research. This system includes a hardware lab device, consumable chips used per experiment, and accompanying data analysis software. Operations focus on providing these components to research institutions.
- Headquarters Berkeley, United States
- Stage Acquired
- SectorsHealthcare
- Website zephyrusbio.com
- Social LinkedIn X YouTube
- Acquired by Bio-Techne (Mar 2016)
- Total Equity Funding$1.5M (USD)
in 2 rounds
- Latest Funding Round$1.5M (USD), Seed
Sep 2014
- InvestorsNIH
& 5 more
- Acquired byBio-Techne
(Mar 2016)
Products & Services of Zephyrus Biosciences
Zephyrus Biosciences offers a comprehensive portfolio of products and services, including Antibodies, ELISA Kits, Simple Plex Assays, and Simple Western Instruments.
Tools for detecting specific proteins in biological samples.
Kits for measuring proteins and molecules in research applications.
Automated assays for fast and reproducible protein measurement.
Devices for complete protein analysis in scientific studies.
Apps and channels of Zephyrus Biosciences
its YouTube channel Bio-Techne has 509 subscribers and 30 videos.
Videos from Zephyrus Biosciences
The most watched videos on Zephyrus Biosciences's YouTube channel, Bio-Techne (509 subscribers). Click a video to play it here.
More on Bio-Techne.
Funding Insights of Zephyrus Biosciences
Zephyrus Biosciences has successfully raised a total of $1.5M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $1.5 million completed in September 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.5M
- Total Rounds 2
- Last Round Seed — $1.5M
- First Round $350,000
(Sep 2014)
- Investors Count 5
All 2 funding rounds of Zephyrus Biosciences with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2014 | $350,000 | Grant | – | – | |
| Sep 2014 | $1.5M | Seed | – | Life Science Angels |
6 investors in total: 6 institutional.
Investors in Zephyrus Biosciences
Zephyrus Biosciences has secured backing from 6 investors, including institutional and venture fund investors. Prominent investors backing the company include NIH, Bio-Techne and Life Science Angels.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Life sciences startups are funded by a non-profit angel network. | lifescienceangels.com | Sunnyvale, United States | ||
Tech & Life Sciences focused VC firm investing in early stage startups in the US | angelsforum.com | Mountain View, United States | ||
Startups are accelerated by Stanford-backed program in Palo Alto. | startx.com | Palo Alto, United States | ||
Investments in life science startups are made by Mission BioCapital. | missionbiocapital.com | San Francisco, United States | ||
Drug discovery services are provided to the biopharma sector. | 1887 | nih.gov | United States | |
Developer of biotech reagents, instruments and clinical diagnostic products | 1981 | bio-techne.com | Minneapolis, United States |
Investor details for Zephyrus Biosciences
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of Zephyrus Biosciences
3 dated milestones of Zephyrus Biosciences across 3 years, from founding to its latest funding, stage changes and deals.
- Founded Zephyrus Biosciences is founded.
- Funding First funding round of $350K.
- Exit Acquired by Bio-Techne.
Competitors of Zephyrus Biosciences
Zephyrus Biosciences has 3 listed competitors in our database, 2 of them funded. They include Bio Rad, Quanterix and Biocare Medical.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| bio-rad.com | 1952 | Hercules, United States | 10 | Portfolio of products and services for life science research and clinical diagnostic markets | ||
| quanterix.com | 2007 | Cambridge, United States | $99.5M | 141 | Assay kits for ultra-sensitive biomarker detection are developed. | |
| biocare.net | 1997 | Concord, United States | $85M | 161 | Primary antibodies and instruments for immunohistochemistry are manufactured. |
Detailed competitors of Zephyrus Biosciences
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Zephyrus Biosciences (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Zephyrus Biosciences
Complete news archive for Zephyrus Biosciences
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Zephyrus Biosciences
Zephyrus Biosciences was founded in 2013 and raised its 1st funding round 1 year after it was founded.
Zephyrus Biosciences is headquartered in Berkeley, United States. It is registered at Berkeley, California, United States.
Zephyrus Biosciences is a funded company, having raised a total of $1.5M across 2 funding rounds to date. The company's 1st funding round was a Grant of $350K, raised on Sep 2014.
Zephyrus Biosciences was founded in 2013 in Berkeley, United States, within the biotechnology sector. The scWestern System is being commercialized to enable single-cell protein analysis for stem cell and cancer research. This system includes a hardware lab device, consumable chips used per experiment, and accompanying data analysis software. Operations focus on providing these components to research institutions.
Zephyrus Biosciences's top competitors include Biocare Medical, Quanterix and Bio Rad.
Zephyrus Biosciences offers Antibodies, ELISA Kits, Simple Plex Assays, and Simple Western Instruments.
Zephyrus Biosciences has 6 investors. Key investors include NIH, Bio-Techne, Life Science Angels, The Angels’ Forum, and StartX.
Yes. Zephyrus Biosciences was acquired by Bio-Techne in March 2016.

